• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巯基化合物对奥美拉唑在离体兔胃腺中抗分泌活性的逆转作用。

Reversal of antisecretory activity of omeprazole by sulfhydryl compounds in isolated rabbit gastric glands.

作者信息

Im W B, Blakeman D P, Sachs G

出版信息

Biochim Biophys Acta. 1985 Apr 22;845(1):54-9. doi: 10.1016/0167-4889(85)90054-0.

DOI:10.1016/0167-4889(85)90054-0
PMID:3978129
Abstract

We have examined the interaction of omeprazole, a gastric antisecretory agent, with endogenous or exogenous sulfhydryl compounds in isolated rabbit gastric glands. The glands exposed to omeprazole (2 microM for 50 min) could recover acid secretory response to dibutyryl-cAMP upon addition of dithiothreitol, cysteine or glutathione. Washing the omeprazole-exposed glands free of the extracellular drug also led to a similar recovery of the acid secretory response. Depletion of cellular glutathione with 2-cyclohexen-1-one had no considerable effect on the secretory response of the glands to dibutyryl-cAMP, but prevented the reversal of the antisecretory effect of omeprazole upon washing or adding exogenous cysteine. Also, the antisecretory potency of omeprazole increased several fold in the glutathione-depleted glands. These observations indicate that cellular glutathione is essential to reactivate the omeprazole-modified enzyme(s), possibly (H+ + K+)-ATPase, in acid secretory process and led us to propose that omeprazole is an agent reacting with sulfhydryl groups.

摘要

我们研究了胃分泌抑制剂奥美拉唑与分离的兔胃腺中内源性或外源性巯基化合物的相互作用。暴露于奥美拉唑(2微摩尔,50分钟)的胃腺在加入二硫苏糖醇、半胱氨酸或谷胱甘肽后,对二丁酰环磷腺苷酸的酸分泌反应能够恢复。将暴露于奥美拉唑的胃腺冲洗以去除细胞外药物,也会导致酸分泌反应出现类似的恢复。用2-环己烯-1-酮消耗细胞内谷胱甘肽对胃腺对二丁酰环磷腺苷酸的分泌反应没有显著影响,但阻止了奥美拉唑的抗分泌作用在冲洗或添加外源性半胱氨酸后逆转。此外,在谷胱甘肽耗尽的胃腺中,奥美拉唑的抗分泌效力增加了几倍。这些观察结果表明,细胞内谷胱甘肽对于在酸分泌过程中重新激活可能被奥美拉唑修饰的酶(可能是(H⁺+K⁺)-ATP酶)至关重要,并使我们提出奥美拉唑是一种与巯基反应的药物。

相似文献

1
Reversal of antisecretory activity of omeprazole by sulfhydryl compounds in isolated rabbit gastric glands.巯基化合物对奥美拉唑在离体兔胃腺中抗分泌活性的逆转作用。
Biochim Biophys Acta. 1985 Apr 22;845(1):54-9. doi: 10.1016/0167-4889(85)90054-0.
2
Inhibitions of acid secretion by E3810 and omeprazole, and their reversal by glutathione.E3810和奥美拉唑对胃酸分泌的抑制作用及其被谷胱甘肽逆转的情况。
Biochem Pharmacol. 1991 Jul 5;42(2):321-8. doi: 10.1016/0006-2952(91)90719-l.
3
Omeprazole, a specific inhibitor of gastric (H+-K+)-ATPase, is a H+-activated oxidizing agent of sulfhydryl groups.奥美拉唑是胃(H⁺-K⁺)-ATP酶的特异性抑制剂,是一种H⁺激活的巯基氧化剂。
J Biol Chem. 1985 Apr 25;260(8):4591-7.
4
By 1023/SK&F 96022: biochemistry of a novel (H+ + K+)-ATPase inhibitor.由1023/SK&F 96022:一种新型(氢离子+钾离子)-ATP酶抑制剂的生物化学
Biochem Pharmacol. 1990 Jun 1;39(11):1799-806. doi: 10.1016/0006-2952(90)90128-8.
5
Inhibitory action of omeprazole on acid formation in gastric glands and on H+,K+-ATPase isolated from human gastric mucosa.奥美拉唑对胃腺酸形成及从人胃黏膜分离出的H⁺,K⁺-ATP酶的抑制作用。
Scand J Gastroenterol. 1986 Apr;21(3):268-72. doi: 10.3109/00365528609003075.
6
Effect of omeprazole on gastric acid secretion by the rat isolated stomach.
Pharmacol Res Commun. 1986 Mar;18(3):257-71. doi: 10.1016/0031-6989(86)90123-2.
7
Specific labelling of gastric H+,K+-ATPase by omeprazole.奥美拉唑对胃H⁺,K⁺-ATP酶的特异性标记。
Biochem Pharmacol. 1988 Jul 1;37(13):2543-9. doi: 10.1016/0006-2952(88)90244-4.
8
Comparison of five antisecretory agents acting via gastric H+/K+-ATPase.
J Physiol Paris. 2000 Jan-Feb;94(1):19-23. doi: 10.1016/s0928-4257(99)00108-4.
9
[Inhibitory action of E3810 on H+,K(+)-ATPase and gastric acid secretion in vitro].
Nihon Yakurigaku Zasshi. 1993 Dec;102(6):389-97. doi: 10.1254/fpj.102.389.
10
Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase.取代苯并咪唑通过阻断(H⁺+K⁺)ATP酶来抑制胃酸分泌。
Nature. 1981 Mar 12;290(5802):159-61. doi: 10.1038/290159a0.

引用本文的文献

1
Gastric H,K-ATPase as a drug target.胃H,K - ATP酶作为一种药物靶点。
Dig Dis Sci. 2006 May;51(5):823-33. doi: 10.1007/s10620-005-9042-8. Epub 2006 Apr 28.
2
Pharmacological aspects of acid secretion.胃酸分泌的药理学方面。
Dig Dis Sci. 1995 Feb;40(2 Suppl):3S-23S. doi: 10.1007/BF02214869.
3
Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.奥美拉唑。对其药效学和药代动力学特性以及在消化性溃疡疾病和佐林格-埃利森综合征中的治疗潜力的初步综述。
Drugs. 1986 Jul;32(1):15-47. doi: 10.2165/00003495-198632010-00002.
4
The sulphoxide moiety of substituted benzimidazoles is essential for inhibition of parietal cell K+/H+-ATPase.取代苯并咪唑的亚砜部分对于抑制壁细胞K+/H+-ATP酶至关重要。
Br J Pharmacol. 1986 Jun;88(2):389-95. doi: 10.1111/j.1476-5381.1986.tb10215.x.